New research suggests testing people’s memory over four weeks could identify who is at higher risk of developing Alzheimer’s disease before it has developed. Importantly,…
A study conducted on mice published in the journal Geroscience has identified the action mechanism of a promising compound against Alzheimer’s disease, developed by the…
Memory loss associated with Alzheimer’s disease (AD) may be able to be restored by inhibiting certain enzymes involved in abnormal gene transcription, according to a…
Today, a clinician can order a blood test to check a patient’s cholesterol or hemoglobin A1c levels—biomarkers that help predict an individual’s risk of cardiovascular…
Late-onset Alzheimer’s disease (LOAD) is the most common form of dementia in the elderly, affecting almost 44 million people worldwide. Despite decades of research, genetic…
A recent preclinical study from scientists at Sunnybrook Research Institute, Canadian Blood Services and the University of Toronto has demonstrated that focused ultrasound improves the…
Caregivers of people with dementia and milder forms of neurocognitive disorder bear a heavy burden. They are constantly confronted with challenging symptoms and behaviors and…
If Alzheimer’s dementia is identified early, at the stage of Mild Cognitive Impairment, for instance, the decline in neural functioning can be stabilized or even…
A novel form of an Alzheimer’s protein found in the fluid that surrounds the brain and spinal cord indicates what stage of the disease a…
Researchers at the Case Western Reserve University School of Medicine have identified a new target in development of Alzheimer’s disease (AD) that could lead to…